KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 68,600 Value ($000) $2,830 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 65,700 Value ($000) $2,551 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 64,600 Value ($000) $1,787 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 71,900 Value ($000) $1,597 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 71,900 Value ($000) $1,422 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 78,600 Value ($000) $1,964 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 78,600 Value ($000) $1,467 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	68,600	$2,830	$40.11	$35.20 - $44.42
Q3 2025	65,700	$2,551	$32.49	$26.27 - $39.00
Q2 2025	64,600	$1,787	$25.46	$18.25 - $30.69
Q1 2025	71,900	$1,597	$20.58	$17.82 - $24.31
Q4 2024	71,900	$1,422	$22.82	$19.47 - $28.15
Q3 2024	78,600	$1,964	$24.36	$17.38 - $27.92
Q2 2024	78,600	$1,467	$18.73	$16.56 - $20.52